GIP agonist

GIP receptor agonist

Incretin action complementary to GLP-1
Combined GIP/GLP-1 agonism gives greater weight loss

Drugs with this mechanism (3)

Retatrutide — Investigational triple GIP/GLP-1/glucagon agonist for obesity.
Tirzepatide — Dual GIP/GLP-1 agonist for diabetes and obesity; exceptional glucose and weight effects.
Tirzepatide (obesity) — Dual GIP/GLP-1 weight-loss drug; also treats obesity-related sleep apnea.

All mechanisms · Open the interactive console ↗